BIOVAIL RECEIVES FDA APPROVAL FOR CITALOPRAM ODT

A A

Biovail has received FDA approval to market an orally disintegrating tablet (ODT) formulation of citalopram hydrobromide (HBr), the active ingredient in Forest Laboratories' antidepressant Celexa. Biovail's ODT product will be available in 10-, 20- and 40-mg tablets.